Nautilus Biotechnology Statistics
Total Valuation
NAUT has a market cap or net worth of $254.16 million. The enterprise value is $187.16 million.
Important Dates
The next estimated earnings date is Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAUT has 127.08 million shares outstanding. The number of shares has increased by 0.56% in one year.
| Current Share Class | 127.08M |
| Shares Outstanding | 127.08M |
| Shares Change (YoY) | +0.56% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 32.25% |
| Owned by Institutions (%) | 17.92% |
| Float | 52.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 175.28 |
| PB Ratio | 1.76 |
| P/TBV Ratio | 1.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.85, with a Debt / Equity ratio of 0.20.
| Current Ratio | 11.85 |
| Quick Ratio | 11.49 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.69% and return on invested capital (ROIC) is -20.18%.
| Return on Equity (ROE) | -33.69% |
| Return on Assets (ROA) | -19.77% |
| Return on Invested Capital (ROIC) | -20.18% |
| Return on Capital Employed (ROCE) | -37.84% |
| Weighted Average Cost of Capital (WACC) | 7.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$449,488 |
| Employee Count | 127 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +152.08% in the last 52 weeks. The beta is 0.75, so NAUT's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +152.08% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 2.13 |
| Relative Strength Index (RSI) | 32.79 |
| Average Volume (20 Days) | 775,718 |
Short Selling Information
The latest short interest is 541,139, so 0.43% of the outstanding shares have been sold short.
| Short Interest | 541,139 |
| Short Previous Month | 760,157 |
| Short % of Shares Out | 0.43% |
| Short % of Float | 1.04% |
| Short Ratio (days to cover) | 1.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -64.12M |
| Pretax Income | -57.09M |
| Net Income | -57.09M |
| EBITDA | -62.50M |
| EBIT | -64.12M |
| Earnings Per Share (EPS) | -$0.45 |
Full Income StatementBalance Sheet
The company has $95.87 million in cash and $28.87 million in debt, giving a net cash position of $67.00 million or $0.53 per share.
| Cash & Cash Equivalents | 95.87M |
| Total Debt | 28.87M |
| Net Cash | 67.00M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 144.42M |
| Book Value Per Share | 1.14 |
| Working Capital | 90.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$49.86 million and capital expenditures -$1.57 million, giving a free cash flow of -$51.43 million.
| Operating Cash Flow | -49.86M |
| Capital Expenditures | -1.57M |
| Depreciation & Amortization | 1.62M |
| Net Borrowing | n/a |
| Free Cash Flow | -51.43M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |